Optimizing the patient journey: Insights from early implementation of long‐acting cabotegravir and rilpivirine in four urban Ryan White‐funded clinics in the United States
Optimizing the LAI-CAB/RPV patient journey requires developing a specialized support framework that is distinct from oral ART protocols. This new treatment modality requires a tailored approach that addresses unique challenges, including facilitating candid discussions about adherence contingencies, managing the physical and psychological aspects of injection experiences, ensuring meaningful and consistent provider relationships amid changing care patterns and providing enhanced support during treatment transitions.
Authors
- Moira McNulty (ORCID: https://orcid.org/0000-0002-9651-254X)
- Matthew D. Hickey (ORCID: https://orcid.org/0000-0001-8913-1602)
- Alicia Dawdani
- John A. Sauceda (ORCID: https://orcid.org/0000-0003-1975-3080)
- Kaylin V. Dance (ORCID: https://orcid.org/0000-0001-6419-7162)
- Lauren Frances Collins (ORCID: https://orcid.org/0000-0002-0170-5454)
- José I. Gutierrez (ORCID: https://orcid.org/0000-0003-3231-0794)
- Priyasha Pareek
- Kimberly A. Koester (ORCID: https://orcid.org/0000-0003-0023-1127)
- Xavier A. Erguera (ORCID: https://orcid.org/0000-0002-7632-0321)
- Mollie Smith (ORCID: https://orcid.org/0009-0002-7240-7865)
- T. Wang
- Mallory O. Johnson
- Jonathan A. Colasanti
- Janet Grochowski
- Elizabeth T. Montgomery
- Katerina A. Christopoulos
- Jon Oskarsson
Institutions
- Emory University (US)
- University of Massachusetts Chan Medical School (US)
- RTI International (US)
- University of California, San Francisco (US)
- University of Chicago (US)
- Grady Health System (US)
- Columbia University (US)
Publication Details
- Journal
- Journal of the International AIDS Society
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/jia2.70082
- Primary Topic
- HIV, Drug Use, Sexual Risk
- Type
- article
- Field-Weighted Citation Impact
- 0.00